Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03895372
What this trial is testing

Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 179
Testing effectiveness (Phase 2)Study completedNCT03614078
What this trial is testing

PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis VulgarisPlaque Psoriasis
PRCL Research Inc. 92
Testing effectiveness (Phase 2)Study completedNCT00443326
What this trial is testing

AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

Who this might be right for
Psoriasis
Amgen 22
Large-scale testing (Phase 3)Study completedNCT01777191
What this trial is testing

Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 204
Post-approval studies (Phase 4)Ended earlyNCT05125679
What this trial is testing

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag Ltd. 15
Large-scale testing (Phase 3)Looking for participantsNCT07326813
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
InventisBio Co., Ltd 477
Large-scale testing (Phase 3)Ended earlyNCT04305327
What this trial is testing

Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
LEO Pharma 12
Testing effectiveness (Phase 2)Study completedNCT00134394
What this trial is testing

Etanercept With Tacrolimus for Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 20
Large-scale testing (Phase 3)Study completedNCT02325219
What this trial is testing

An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 192
Large-scale testing (Phase 3)Study completedNCT01235442
What this trial is testing

Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 592
Not applicableEnded earlyNCT00184366
What this trial is testing

Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Norwegian University of Science and Technology 96
Early research (Phase 1)Study completedNCT06738277
What this trial is testing

This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS).

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Biocon Biologics UK Ltd 186
Post-approval studies (Phase 4)Study completedNCT03587194
What this trial is testing

Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 50
Large-scale testing (Phase 3)Ended earlyNCT03556202
What this trial is testing

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,936
Testing effectiveness (Phase 2)Study completedNCT06073119
What this trial is testing

Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

Who this might be right for
Psoriasis
Sanofi 221
Large-scale testing (Phase 3)Study completedNCT03047395
What this trial is testing

Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

Who this might be right for
Psoriasis
AbbVie 2,170
Large-scale testing (Phase 3)Study completedNCT04435600
What this trial is testing

Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

Who this might be right for
Psoriasis
AbbVie 139
Large-scale testing (Phase 3)Study completedNCT02684357
What this trial is testing

BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 577
Large-scale testing (Phase 3)Study completedNCT01177800
What this trial is testing

Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Xian-Janssen Pharmaceutical Ltd. 129
Post-approval studies (Phase 4)Study completedNCT05969223
What this trial is testing

Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis

Who this might be right for
Genital PsoriasisScalp Psoriasis
AbbVie 214
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation